Serina Therapeutics (SER) Operating Income (2018 - 2025)
Historic Operating Income for Serina Therapeutics (SER) over the last 8 years, with Q3 2025 value amounting to -$6.4 million.
- Serina Therapeutics' Operating Income fell 2033.13% to -$6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.4 million, marking a year-over-year decrease of 10753.24%. This contributed to the annual value of -$17.0 million for FY2024, which is 44483.86% down from last year.
- As of Q3 2025, Serina Therapeutics' Operating Income stood at -$6.4 million, which was down 2033.13% from -$5.6 million recorded in Q2 2025.
- In the past 5 years, Serina Therapeutics' Operating Income ranged from a high of $241000.0 in Q4 2023 and a low of -$6.4 million during Q3 2025
- Its 5-year average for Operating Income is -$2.8 million, with a median of -$2.1 million in 2022.
- In the last 5 years, Serina Therapeutics' Operating Income surged by 11352.41% in 2023 and then plummeted by 240248.96% in 2024.
- Quarter analysis of 5 years shows Serina Therapeutics' Operating Income stood at -$1.9 million in 2021, then rose by 4.55% to -$1.8 million in 2022, then surged by 113.52% to $241000.0 in 2023, then plummeted by 2402.49% to -$5.5 million in 2024, then decreased by 15.19% to -$6.4 million in 2025.
- Its last three reported values are -$6.4 million in Q3 2025, -$5.6 million for Q2 2025, and -$5.9 million during Q1 2025.